(Q35602099)

9 August 2017

1 reference

title

Blood coagulation factor VIII: An overview (English)

1 reference

9 August 2017

Bhopale GM

1

1 reference

9 August 2017

Nanda RK

series ordinal

2

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

published in

Journal of Biosciences

1 reference

9 August 2017

volume

28

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

783-789

1 reference

Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin

9 August 2017

cites work

1 reference

12 December 2020

Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII

1 reference

12 December 2020

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

1 reference

12 December 2020

Factor VIII structure and function

1 reference

12 December 2020

A role for the C2 domain of factor VIII in binding to von Willebrand factor

1 reference

12 December 2020

The international registry of immune tolerance: 1994 update

1 reference

12 December 2020

Immune tolerance: a synopsis of the international experience

1 reference

12 December 2020

A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate

1 reference

12 December 2020

Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.

1 reference

12 December 2020

Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A

1 reference

12 December 2020

Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group

1 reference

12 December 2020

Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity

1 reference

12 December 2020

Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A.

1 reference

12 December 2020

Molecular etiology of factor VIII deficiency in hemophilia A.

1 reference

12 December 2020

The transfusion-associated transmission of parvovirus B19.

1 reference

12 December 2020

Life-threatening human parvovirus B19 infection in immunocompetent haemophilia

1 reference

12 December 2020

Viral safety of clotting factor concentrates

1 reference

12 December 2020

Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate

1 reference

12 December 2020

Haemophilia A and haemophilia B: molecular insights.

1 reference

12 December 2020

Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production.

1 reference

12 December 2020

Properties of anti-factor VIII inhibitor antibodies in hemophilia A patients

1 reference

12 December 2020

Characterization of the human factor VIII gene

1 reference

12 December 2020

The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor

1 reference

12 December 2020

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor

1 reference

12 December 2020

Management of haemophilia in the developing world

1 reference

12 December 2020

A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology

1 reference

12 December 2020

Haemophilia A: mutation type determines risk of inhibitor formation

1 reference

12 December 2020

Structure of human factor VIII

1 reference

12 December 2020

A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group

1 reference

12 December 2020

Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII)

1 reference

12 December 2020

Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ

1 reference

12 December 2020

Toward gene therapy for hemophilia A: long-term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice.

1 reference

12 December 2020

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

12 December 2020

Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor

1 reference

12 December 2020

Distribution of factor VIII mRNA and antigen in human liver and other tissues

1 reference

12 December 2020

The life cycle of coagulation factor VIII in view of its structure and function

1 reference

12 December 2020

Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions

1 reference

12 December 2020

TT virus does not contaminate first-generation recombinant factor VIII concentrate

1 reference

12 December 2020

The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor

1 reference

12 December 2020

A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells

1 reference

12 December 2020

Biological regulation of factor VIII activity

1 reference

12 December 2020

The haemophilia A mutation search test and resource site, home page of the factor VIII mutation database: HAMSTeRS.

1 reference

12 December 2020

Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate

1 reference

12 December 2020

Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes

1 reference

12 December 2020

Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII

1 reference

12 December 2020

Intracellular accumulation of factor VIII induced by missense mutations Arg593-->Cys and Asn618-->Ser explains cross-reacting material-reduced haemophilia A.

1 reference

12 December 2020

Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide.

1 reference

12 December 2020

Advances toward gene therapy for hemophilia at the millennium

1 reference

12 December 2020

TT virus contaminates first-generation recombinant factor VIII concentrates

1 reference

12 December 2020

Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells

1 reference

12 December 2020

Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A

1 reference

12 December 2020

Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene

1 reference

12 December 2020

The hemophilias--from royal genes to gene therapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02708439

1 reference

9 August 2017

1 reference